AllDocs -> cancers

Corporate Medical Policy Colon Cancer Screening File Name: colon_cancer_screening Policy Number: SUR6164 Origination: 12/2000 Last Review: 6/2002 Next Review: 6/2004 Description of Procedure or Service When colorectal cancer is diagnosed at an early, localized state, five-year survival is 90%, yet only 37% of incident cases are diagnosed while still localized. The same methods used to detect colorectal cancers at early, curable stages can also identify and remove adenomas, which give rise to colorectal cancer . Methods for early detection can therefore actually prevent colorectal cancer . Definitions of Early Detection Methods are as follows: ? Fecal Occult Blood Test (FOBT) - FOBT is a laboratory procedure that refers to the implementa- tion of the protocol for collecting and testing six samples from three consecutive stools ...

Screening for Colon Cancer Regina Kovach, MD November 9, 2000 Page 2 Colorectal Cancer - Burden of Suffering • Third most commonly diagnosed cancer in U.S. • Second most common cause of cancer death – significant morbidity: surgical resection, colostomy, radiation therapy, chemotherapy • Average patient dying of colon cancer loses 13 years of life Page 3 Colorectal Cancer -Five year Survival • Localized disease 90% • Regional disease 60% • Distant metastases 5% 60% have regional or distant metastases at time of diagnosis Page 4 Evidenced Based Clinical Practice Guidelines for Screening • Agency for Health Care Policy and Research (AHCPR) • American Gastroenterologic Association • U. S. Preventive ...

(formalin fixed) A203: Colon cancer tissues For research use only Specifications: •No. of cases: 50 •Tissue type: Colon cancer tissues •No. of spots: 2 spots from each cancer case ( 100 spots) 4 non-neoplastic spots (4 spots) •Total spots: 104 •Corresponding normal tissues with cancers: No •Diameter: 1.0 mm Documents: •Product specification: layout, summary of tissue spots •H&E stained images •Detailed pathological information Layout: Page 2 (formalin fixed) A203: Colon cancer tissues For research use only Summary of tissue spots No. Sex Age Key Word Surgery Grade TNM Stage 1 1, 2 m 86 Rectum: adenocarcinoma resection G1 B1 2 3, 4 m 56 Rectum: adenocarcinoma ...

La Crosse County Health Department: Nutrition June 11, 2004 Not only is calcium good for your bones and teeth, but new research has found that calcium may be linked with prevention of colon cancer and high blood pressure. In addition to this it may also be a helpful tool for weight management. Colon Cancer ?A study published in the New England Journal of Medicine in 1999 found that calcium intake of 1200 mg per day may help reduce recurrent colon polyps, a risk factor for colon cancer . ? The rationale behind this is that as unabsorbed calcium travels through the colon , it binds with cancer promoters and both are then excreted out of the body Blood Pressure ?An adequate supply of calcium helps muscles (including your heart muscle) do their work of contracting and relaxing ?Calcium also appears ...

1 PFEM#000160 Screening for Colon Cancer What is colon cancer ? Colon cancer is the second leading cancer killer in the United States and the third most common cancer overall. It begins as little non-cancerous growths (polyps) in the colon and rectum. If left undetected, they can become cancerous and spread to other organs. Why is it important to get screened? About 60% of people with colon cancer have cancer that has spread at the time of diagnosis. Early detection and removal of the polyps is key to preventing colon cancer . Who should be screened? Anyone who: • Is 50 and older • Eats foods high in fat, high in calories, and low in fiber • Has a history of colon polyps • Has a family history of colon cancer • Has ulcerative colitis • Has had cancer ...

REVISED 7 JUNE 2004 DIRECTORY OF COLON CANCER SPECIALIST TEAMS EASTERN HEALTH AND SOCIAL SERVICES BOARD COLON CANCER UNIT based at BELFAST CITY HOSPITAL & ROYAL GROUP OF HOSPITALS unless otherwise stated Belfast City Hospital - Telephone 028 90 263810 Royal Group of Hospitals - Telephone 028 90 240503 STATUS NAME BASE HOSPITAL Lead Clinician Mr R J Maxwell RHT Specialist Surgeon Mr K Gardiner Mr S T Irwin Mr K Khosraviani Mr V Loughlin Mr A Kennedy Mr D Carey RHT RHT RHT BCH/LVH BCH/LVH BCH Gastroenterologist Dr JSA Collins Dr RGP Watson Dr B Johnston Dr S Johnston RHT RHT RHT BCH Chemotherapy Nurse As per Oncology BCH Radiologist (Lead) ...

OncoLog • October 2003 7 P H Y S I C I A N S : T H I S P A T I E N T I N F O R M A T I O N S H E E T I S Y O U R S T O C O P Y A N D P A S S O N T O P A T I E N T S . For more information, contact your physician or contact the M. D. Anderson Information Line: ? (800) 392-1611, Option 3, within the United States, or ? (713) 792-3245 in Houston and outside the United States. October 2003 ©2003 The University of Texas M. D. Anderson Cancer Center Note to Self: Get Screened for Colon Cancer T his memo is for every- one who is putting off colon cancer screening. You may have come across this article on your own, or it may have been given to you by someone who cares about you. No matter how it came to you, this could be the most ...

INTRODUCTION Colorectal cancer is still a leading cause of cancer deaths in the United States and is increasing at an alarming rate in Asia (1, 2). Cancer chemoprevention is a discipline of cancer research emerging from its infancy 20 yr ago to now gain center stage in the armamentarium against cancer (3). Yet it has not abandoned its founding principles of discovery of natural and man-made agents that inhibit the initiation, promotion, or progression of cancer . The pioneering efforts of Wattenberg (4, 5) first focused the search for chemopre- ventive agents by examining the diet for them. Dietary pat- terns may account for wide differences in the risk for lead- ing cancers across the world. It was logical to propose that dietary factors, in countries with populations at low risk for certain cancers could be identified and exploited for use in man as cancer inhibitors ...

Roger Ladouceur, MSc, MD, CCMF, FCMF Presented at Débat: Contre Le Dépistage du Cancer du Colon , October 2003 4 Arguments Against Colon Cancer Screening I t has been long acknowledged that screening for colorectal cancer reduces associated deaths. In fact, it was in 1993 that the results of the Minnesota Colon Cancer Control Study were published. The study showed that annual fecal occult blood testing (FOBT), followed by, if required, a colonoscopy or a barium enema with or without sigmoidoscopy, reduced mor- tality by 33% within a 13-year period. 1 Two other studies have established the advantages of the screening by showing that biennial FOBT reduced associated mortality by 18% in the first testing and 15% in the second. 2,3 Many organizations have since taken a posi- tion in favour of colorectal ...

Gene expression profiling of colon cancer reveals a broad molecular repertoire in 5-fluorouracil resistance W.M. Schmidt 1 , M. Kalipciyan 2 , E. Dornstauder 1 , B. Rizovski 2 , R. Sedivy 3 , G.G. Steger 2 , M.W. Müller 1 and R.M. Mader 2 1 VBC-Genomics Bioscience Research Inc., 2 Department of Medicine I, Clinical Division of Oncology, and 3 Department of Clinical Pathology, University Hospital, Vienna Austria Molecular resistance to 5-fluorouracil Introduction Resistance to anticancer drugs is a major obstacle to chemotherapy of human cancer . In patients with metastasized colorectal carci- noma, resistance to the widely used antimeta- bolite 5-fluorouracil seriously limits therapeu- ...

Oncology This article is based on the conclusions reached at the 1st International Union Against Cancer (UICC) International Workshop on Facilitating Screening for Colorecatal Cancer : An International Agenda, which took place in Oslo, 28–30 June 2002. The participants of this workshop were: Paul Rozen, Co-Chair (Israel); Michael Pignone, Co-Chair (US); Massimo Crespi (Italy); Dominique Criblez (Switzerland); Samy Ahmed El-Badwy (Egypt); Roger Leicester (UK); Szabolcs Otto (Hungary); Christian Pox (Germany); Mike Richard (UK); Daniel Smith (US); Stephen Spann (US); and Graeme P Young (Australia). I n t r o d u c t i o n Colorectal cancer (CRC) is an important cause of morbidity and mortality throughout the developed and industrialising/Westernising world. 1 Aetiological causes include the ‘Western’ or industrialised lifestyle, ...

colon cancer Cost Effectiveness Issues in Genetics Click to add sub-title Overview Principles of economic evaluation of medical technologies, applied to genetics Genetic screening Pharmacogenomics Impact on health care delivery and costs Genetic Screening Testing persons for susceptibility to certain diseases Contrast to diagnostic testing (e.g., Down’s syndrome) Persons with a positive test are more susceptible to developing the disease than the general population Those being tested do not currently have the disease Considerations for Economics and Genetic Screening Prevalence of the genetic variant Mutations (<1% of population) Single nucleotide polymporphisms and haplotypes (collection of SNPs on a chromosome) 1%-50% of population Characteristics ...

l del file contenuto in http://www.jonrobison.net/Paradigms-His-Story.ppt . G o o g l e crea automaticamente la versione .html dei documenti durante la scansione del Web. Per inserire un segnalibro o un collegamento alla pagina, utilizzare il seguente URL: http://www.google.com/search?q=cache:Ugh_NZ3gQMAJ:www.jonrobison.net/Paradigms-His-Story.ppt+allintitle:+colon+cancer+filetype:pdf+OR++filetype:doc+OR+filetype:ppt+OR++filetype:xls+OR+filetype:rtf&hl=it&lr=lang_en Google non è collegato agli autori di questa pagina e non è responsabile del suo contenuto. I termini specificati sono presenti solamente in collegamenti che rimandano alla seguente pagina: allintitle colon cancer PARADIGMS A PARADIGM IS: “ a frame of reference from which we determine how we feel about and interact with our surroundings ” Willis Harman, Global Mind Change ...

Frequently Asked Questions about Cancer of the Colon and the Rectum What is cancer of the colon and the rectum? Cancer is a disease in which certain body cells don’t function right, divide very fast, and produce too much tissue that forms a tumor. The colon and rectum are parts of the body's digestive system, which removes nutrients from food and stores waste until it passes out of the body. Together, the colon and rectum form a long, muscular tube called the large intestine (also called the large bowel). Cancer that begins in the colon is called colon cancer . Cancer that begins in the rectum is called rectal cancer . Cancers affecting either of these organs also may be called colorectal cancer . Why should I be concerned about cancer of the colon and the rectum? Colorectal cancer affects an equal number of women and men each year, and ...

INTRODUCTION Colorectal cancer is still a leading cause of cancer deaths in the United States and is increasing at an alarming rate in Asia (1, 2). Cancer chemoprevention is a discipline of cancer research emerging from its infancy 20 yr ago to now gain center stage in the armamentarium against cancer (3). Yet it has not abandoned its founding principles of discovery of natural and man-made agents that inhibit the initiation 1980s the National Cancer Institute (U.S.A.) established within its structure a chemoprevention screening program to identify promising agents for rapid development into clinical trial agents. This program encompassed a tier of strategies to first select candidate agents, evaluate these agents in in vitro based test systems (often involving human tumor cell lines), then test the most promising agents in short-term animal models for chemoprevention efficacy ...

[ CANCER RESEARCH 64, 3444 –3451, May 15, 2004] Telomeric Recombination in Mismatch Repair Deficient Human Colon Cancer Cells after Telomerase Inhibition Oliver E. Bechter, 1 Ying Zou, 2 William Walker, 2 Woodring E. Wright, 2 and Jerry W. Shay 2 1 University of Innsbruck, Department of Internal Medicine, Innsbruck, Austria and 2 University of Texas Southwestern Medical Center, Department of Cell Biology, Dallas, Texas ABSTRACT The majority of human malignancies use telomerase to maintain te- lomere homeostasis. Antitelomerase therapy is therefore a promising approach for a cancer -specific therapy. The alternative lengthening of telomeres pathway (ALT) is a recombination-based, telomerase-independ- ent mechanism of telomere length control. It ...

This is a sample of the informational resources available from the Community Health Library. The library’s services and resources are directed toward the health consumer to enable them to make informed health decisions. Materials are intended to provide general information. Please refer specific medical questions to your physician. VAN K. SMITH COMMUNITY HEALTH LIBRARY Located in St. John’s Cancer Center 2055 SOUTH FREMONT SPRINGFIELD, MISSOURI 65804-2263 417-820-2539 or 800-432-2273 Open Monday-Friday, call for current hours of service Visit us on the World Wide Web at www.stjohns.com/libraries/vanksmith COLON AND RECTAL CANCER A sample of the informational resources available from St. John’s Community Health Library Internet Resources Links from MedlinePlus www.nlm.nih .gov/medlineplus/colorectalcancer.html • the National Library of Medicine’s web site ...

MDACC Colon Cancer (Page 1 of 3) ADJUVANT THERAPY PRIMARY TREATMENT PATHOLOGIC FINDINGS INITIAL EVALUATION* CLINICAL PRESENTATION PATHOLOGIC STAGE Completely removed No adjuvant therapy CIS Adenomatous polyp with noninvasive carcinoma (CIS) Adenomatous polyp with invasive cancer Ulcerative/invasive nonobstructing lesion No primary treatment Residual adenoma Repeat colonoscopy immediately Surveillance Resectable Unresectable Stage I T1-2 N0 M0 Stage II T3-4 N0 M0 Poorly differentiated or fragmented specimen or T2 or greater or lymph or vascular invasion or residual lesion or mass T1, margins negative (no adenocarcinoma within 3 mm from cauterized edge), well or moderately differentiated, ...

Colon Cancer Incidence, Mortality, and Colon Cancer Incidence, Mortality, and Screening in New York City: Screening in New York City: Taking a Radical New Approach Taking a Radical New Approach Application for CME credit has been filed with the American Academy of Family Physicians. Determination of credit is pending The AAFP is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to sponsor Continuing Medical Education. Lorna Thorpe, Ph.D. NYC DOHMH – Division of Epidemiology CDC - Nat’l Center for Chronic Disease Prevention and Health Promotion Page 2 Colon Cancer Prevention and Colon Cancer Prevention and Control Control • Colon cancer is the 2 nd leading cause ...

Colon Cancer Bowl-a-thon What’s the Big Deal about colon cancer ? Colon cancer is a BIG problem. It’s very common, and it’s very quiet. Colon cancer is the second most common cause of cancer -related deaths in our country. It doesn’t care about sex, race, or religion. It’s an equal opportunity killer. And it’s a silent killer. Most people don’t have symptoms of colon cancer until the disease is advanced. The good news about colon cancer is that we can usually find its precursor, the polyp, before it becomes a full-fledged cancer . Not only can we find it, we CAN destroy it. Consider it a preemptive strike against colon cancer . That’s why we’re hosting the “Flush Colon Cancer in the Bowl” -a-thon. Let’s take a “strike” at colon cancer . You can ...

colon cancer Colorectal Cancer Endpoints Workshop November 12, 2003 INTRODUCTORY REMARKS Dr. Pazdur welcomed everyone in attendance and noted that the purpose of this meeting was to have a wide-ranging discussion about the positive and negative aspects of various endpoints for trials of drugs to treat colorectal cancer . By statute, FDA can take advice related to oncologic drugs only from the Oncology Drugs Advisory Committee (ODAC). The meeting began with presentations by FDA staff on the regulatory background to the issue of endpoints in trials of cancer drugs. The panel then heard presentations on specific issues relating to endpoints for drug approvals in the colorectal cancer setting. In some cases, speakers framed their presentations as arguments for a particular position. Members of the panel then debated the issues raised by the speaker and offered alternative viewpoints. ...

Cell, Vol. 93, 705–716, May 29, 1998, Copyright 1998 by Cell Press Cyclooxygenase Regulates Angiogenesis Induced by Colon Cancer Cells COX-1 and COX-2. COX-1 is constitutively expressed in many tissues and cell types (Williams et al., 1997) but in some cases is increased during differentiation (Smith Masahiko Tsujii, †‡ Sunao Kawano, † Shingo Tsuji, † Hitoshi Sawaoka, † Masatsugu Hori, † and Raymond N. DuBois* ‡ et al., 1993). By contrast, the expression of COX-2 is * Departments of Medicine and Cell Biology frequently up-regulated by mitogens, cytokines, and tu- Vanderbilt University Medical Center mor promoters. Greater than 80% of colon cancers in VA Medical Center humans have increased COX-2 levels when compared Nashville, Tennessee 37232 ...

Sveriges Lantbruksuniversitet 2004-04-26 D D i i e e t t a a n n d d c c o o l l o o r r e e c c t t a a l l c c a a n n c c e e r r By Johanna Stropp and Maria Svensson Supervisor: Margarita Jägerstad and Cornelia Witthöft Human nutrition course, 5 credits Page 2 Introduction In the western world cancer is one of the most common diseases, causing the second highest number of mortalities, after heart related diseases. Cancer can appear in any multicellular organism where cells are committed to collaborate but where mutations, competition or natural selection is operating within the somatic cells. Abnormal cell birth, death, habitats and territorial limitations are among the basics for developing cancer . Mutations of the p 53 gene are the most common genetic lesion in human cancer , causing ...

Total Male Female 1982-1992 Obs Exp SIR 95% CI Obs Exp SIR 95% CI Obs Exp SIR 95% CI Ashfield 8 8.2 98 42—193 3 4.9 NC NC 5 3.3 152 49—355 Buckland 11 10.1 108 54—195 9 5.5 163 74—309 2 4.6 NC NC Charlemont 6 6.1 99 36—215 6 3.5 171 62—372 0 2.6 NC NC Conway 8 6.5 123 53—242 3 3.6 NC NC 5 2.9 171 55—399 Deerfield 24 28.0 86 55--128 12 15.0 80 41—140 12 13.0 92 47—161 Florida 1 3.4 NC NC 0 1.9 NC NC 1 1.5 NC NC Hawley 1 2.0 NC NC 1 1.3 NC ...

Contact: William A. Hockett Vice President of Corporate Communications (801) 584-3600 Email: bhockett@myriad.com www.myriad.com FOR IMMEDIATE RELEASE New Colon Cancer Gene Licensed Exclusively to Myriad Genetics Myriad’s Predictive Medicine Sample Flow Continues to Grow Salt Lake City, April 14, 2004 - Myriad Genetics, Inc. (Nasdaq: MYGN), announced today that it has licensed exclusive rights in the United States to detect mutations in an important new colon cancer gene. Myriad believes that the new colon cancer gene, known as Mut Y Homolog (MYH), will provide improved sensitivity and predictive utility to the Company’s COLARIS® product line for detecting all major forms of hereditary colon cancer . The Company expects to introduce the enhanced test during the next quarter as an integral component of its COLARIS range of ...

D:\Word\2002Guidelines\BCH\ Colon .doc Page 1 of 2 Clinical Guideline: Colon Cancer Screening Introduction There is good evidence to support screening average risk individuals for colon cancer . Screening should be implemented beginning at age 50 for average risk individuals. Three randomized controlled trials have demonstrated reduced mortality from colon cancer with fecal occult blood testing programs (See references 3, 4, and 5). No randomized clinical trial has yet been reported using flexible sigmoidoscopy, however this screening method appears promising when used at 5 year intervals. Guideline Statement Buffalo Community Health recommends colon cancer screening of all average risk members age 50 through 80. After the age of 80, it will be at physician and patient discretion. The following screening methods are recommended: • Annual Fecal Occult ...

Desired Qualifications for an Executive Director of the Colon Cancer Alliance The top areas of expertise and accountability for an executive director of a special interest national organization, such as the Colon Cancer Alliance, should include: General Description: The Executive Director must have a demonstrated commitment to the issues of personal and community health and well-being, with a particular focus on colorectal cancer and cancer awareness; a passion for innovation, education and research to help the tens of thousands of individuals impacted by the issue; and the expertise necessary to inform the community, impact public policy, and raise the significant and critical funds necessary to further the mission of CCA. Major Responsibilities include: Be an effective voice within the organization and the national community on behalf of those affected by colorectal cancer ...

1.) REUTERSHEALTH A. Prostate Cancer therapy not tied to colon cancer ," by Megan Rauscher (Reuters Health, March 29, 2004). http://www.reutershealth.com/archive/2004/03/29/eline/links/20040329elin019.html B. "Gene works with pesticides to up Parkinson's risk" (Reuters Health, Apr. 2, 2004). http://www.reutershealth.com/archive/2004/04/01/eline/links/20040401elin022.html 2.) EUREKALERT A. "Soy consumption could help prevent prostate cancer and male pattern baldness," (Eurekalert [American Association for the Advancement of Science], March 29, 2004). http://www.eurekalert.org/pub_releases/2004-03/chmc-scc032904.php B. "Black men less likely to be treated for aggressive prostate cancer , UMHS study finds," (Eurekalert [American Association for the Advancement of Science], March 29, 2004). http://www.eurekalert.org/pub_releases/2004-03/uomh-bml032904.php ...

MJA Vol 180 5 April 2004 341 MEDICINE AND THE LAW The Medical Journal of Australia ISSN: 0025-729X 5 April 2004 180 7 341-342 ©The Medical Journal of Australia 2004 www.mja.com.au Medicine and the Law T HERE ARE IMPOR TANT DISTINCTIONS to be made between the inquisitorial process of a tribunal, such as the South Australian Workers Compensation Tribunal, and the adversarial process of the courts. To quote the renowned English Law Lord, Lord Devlin: In the [adversarial process], the judge presides at the trial, directs the proceedings and rules on the law; he is not there to hold an inquiry. It is quite different from the [inquisitorial process] where witnesses are summoned by the court and examined by the judges, the role of counsel being to tender a witness, and ask supplementary questions. 1 A tribunal ...